CHARLES POLLACK

Meeting the imperative to deliver efficient health care not only demands that we recognize and treat individual patients; we must also define strategies to optimize patient flow and resource utilization. Acute bacterial skin and skin structure infections (ABSSSI) have become a challenging medical problem associated with high direct and indirect costs to both the medical system and society. Infections due to bacteria with resistance to previously effective antimicrobials such as methicillin-resistant Staphylococcus aureus (MRSA) are increasing in incidence and have led to higher rates of complications and hospitalizations. MRSA has emerged as the most common cause of purulent infections in the United States and many other regions... In 2013, to identify more clearly a severe subset of skin and soft tissue infections (SSTI) that would typically be treated with parenteral antibiotic therapy, the United States (US) Food and Drug Administration (FDA) issued guidance that standardized the..